These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25615025)

  • 1. Meta-analysis of association between the +49A/G polymorphism of cytotoxic T-lymphocyte antigen-4 and thyroid associated ophthalmopathy.
    Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
    Curr Eye Res; 2015; 40(12):1195-203. PubMed ID: 25615025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
    Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
    Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
    Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
    Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of cytotoxic T lymphocyte-associated antigen-4+49A/G polymorphism with childhood type 1 diabetes mellitus: a meta-analysis].
    Luo SY; Tan LN; Wei HY; Zhang YD; Chen YX
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Sep; 14(9):683-8. PubMed ID: 22989439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A deeper understanding of the association between CTLA4 +49A/G and acute rejection in renal transplantation: an updated meta-analysis.
    Gao JW; Zhou ZH; Guo SC; Guo YF; Guo F
    Ren Fail; 2015 Feb; 37(1):165-74. PubMed ID: 25299395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
    Yi B; Pei Y; Wang C; Jiang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
    Zhu CL; Huang Q; Liu CH; Xie F
    Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
    Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.
    Han S; Zhang S; Zhang W; Li R; Li Y; Wang Z; Xie Y; Mao Y
    Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
    Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
    Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.
    Chang WW; Zhang L; Yao YS; Su H
    Mol Biol Rep; 2012 Sep; 39(9):9159-65. PubMed ID: 22718509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cytotoxic T-lymphocyte antigen 4 +49A/G gene polymorphism with acute rejection risk in renal transplantation.
    Yang CH; Chen XX; Chen L; Zheng DH; Liu QS; Xie WF
    Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28333403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cytotoxic T-lymphocyte associated antigen 4 gene polymorphism with type 1 diabetes mellitus: a meta-analysis.
    Tang ST; Tang HQ; Zhang Q; Wang CJ; Wang YM; Peng WJ
    Gene; 2012 Oct; 508(2):165-87. PubMed ID: 22964358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis.
    Chen Z; Fei M; Fu D; Zhang L; Ma Y; Wang Y; Zhang F; Xia Q; Wang X
    Gene; 2013 Mar; 516(2):263-70. PubMed ID: 23261825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis.
    Han S; Li Y; Mao Y; Xie Y
    Hum Genet; 2005 Oct; 118(1):123-32. PubMed ID: 16133179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis.
    Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH
    Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cytotoxic T-lymphocyte antigen-4 +49A/G polymorphism and colorectal cancer risk: a meta-analysis.
    He L; Deng T; Luo HS
    Int J Clin Exp Med; 2015; 8(3):3752-60. PubMed ID: 26064271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-Analysis of CTLA-4 +49 Gene Polymorphism and Susceptibility to Graves' Disease.
    Huang F; He Q; Jiao X; Zhang H; Chang Q
    Crit Rev Eukaryot Gene Expr; 2020; 30(5):377-390. PubMed ID: 33389876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.